AMANDA BONHAM: Open Payments
NPI 1629449244 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 10 payments from 6 companies in 2025. Trend: 2023 $373 · 2024 $4,584 · 2025 $721
Food & beverage: $536Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $321 |
| Novartis Pharmaceuticals Corporation | 2 | $140 |
| SEAGEN INC. | 1 | $95 |
| Incyte Corporation | 1 | $90 |
| Pharmacosmos Therapeutics Inc. | 1 | $48 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: RYBREVANT, KISQALI, ERLEADA, Jakafi, MONOFERRIC, KEYTRUDA, PLUVICTO.
Industry payments across OH — which companies pay providers there.
